Risk of thyroid cancer, brain cancer, and non-Hodgkin lymphoma after adult leukemia: a nationwide study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Risk of thyroid cancer, brain cancer, and non-Hodgkin lymphoma after adult leukemia : a nationwide study. / Nielsen, Sune F; Bojesen, Stig E; Birgens, Henrik S; Nordestgaard, Børge G.

In: Blood, Vol. 118, No. 15, 2011, p. 4062-9.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Nielsen, SF, Bojesen, SE, Birgens, HS & Nordestgaard, BG 2011, 'Risk of thyroid cancer, brain cancer, and non-Hodgkin lymphoma after adult leukemia: a nationwide study', Blood, vol. 118, no. 15, pp. 4062-9. https://doi.org/10.1182/blood-2011-02-337170

APA

Nielsen, S. F., Bojesen, S. E., Birgens, H. S., & Nordestgaard, B. G. (2011). Risk of thyroid cancer, brain cancer, and non-Hodgkin lymphoma after adult leukemia: a nationwide study. Blood, 118(15), 4062-9. https://doi.org/10.1182/blood-2011-02-337170

Vancouver

Nielsen SF, Bojesen SE, Birgens HS, Nordestgaard BG. Risk of thyroid cancer, brain cancer, and non-Hodgkin lymphoma after adult leukemia: a nationwide study. Blood. 2011;118(15):4062-9. https://doi.org/10.1182/blood-2011-02-337170

Author

Nielsen, Sune F ; Bojesen, Stig E ; Birgens, Henrik S ; Nordestgaard, Børge G. / Risk of thyroid cancer, brain cancer, and non-Hodgkin lymphoma after adult leukemia : a nationwide study. In: Blood. 2011 ; Vol. 118, No. 15. pp. 4062-9.

Bibtex

@article{691f255fda014601b10efe88fd330194,
title = "Risk of thyroid cancer, brain cancer, and non-Hodgkin lymphoma after adult leukemia: a nationwide study",
abstract = "Patients with childhood leukemia surviving into adulthood have elevated risk of developing thyroid cancer, brain cancer, and non-Hodgkin lymphoma (NHL); these risks cannot automatically be extrapolated to patients surviving adult leukemia. We tested whether survivors of adult leukemia are at increased risk of developing thyroid cancer, brain cancer, and NHL. We included the entire adult Danish population (14 years of age or older), in a 28-year follow-up period from 1980 through 2007, composed of 6 542 639 persons; during this period, 18 834 developed adult leukemia, 4561 developed thyroid cancer, 13 362 developed brain cancer, and 15 967 developed NHL. In nested studies using Cox regression models on individual participant data, we found that, after adult leukemia, the multivariate adjusted hazard ratios were 4.9 (95% confidence interval [CI], 2.8-8.5) for thyroid cancer, 1.9 (95% CI, 1.2-3.1) for brain cancer, and 3.3 (95% CI, 2.5-4.4) for NHL. Corresponding hazard ratios after childhood leukemia were 10.4 (95% CI, 0.4-223) for thyroid cancer, 7.2 (95% CI, 2.0-26) for brain cancer, and 6.5 (95% CI, 0.4-110) for NHL. Patients with adult leukemia have excess risk of thyroid cancer, brain cancer, and NHL, similar to patients with childhood leukemia.",
author = "Nielsen, {Sune F} and Bojesen, {Stig E} and Birgens, {Henrik S} and Nordestgaard, {B{\o}rge G}",
year = "2011",
doi = "http://dx.doi.org/10.1182/blood-2011-02-337170",
language = "English",
volume = "118",
pages = "4062--9",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "15",

}

RIS

TY - JOUR

T1 - Risk of thyroid cancer, brain cancer, and non-Hodgkin lymphoma after adult leukemia

T2 - a nationwide study

AU - Nielsen, Sune F

AU - Bojesen, Stig E

AU - Birgens, Henrik S

AU - Nordestgaard, Børge G

PY - 2011

Y1 - 2011

N2 - Patients with childhood leukemia surviving into adulthood have elevated risk of developing thyroid cancer, brain cancer, and non-Hodgkin lymphoma (NHL); these risks cannot automatically be extrapolated to patients surviving adult leukemia. We tested whether survivors of adult leukemia are at increased risk of developing thyroid cancer, brain cancer, and NHL. We included the entire adult Danish population (14 years of age or older), in a 28-year follow-up period from 1980 through 2007, composed of 6 542 639 persons; during this period, 18 834 developed adult leukemia, 4561 developed thyroid cancer, 13 362 developed brain cancer, and 15 967 developed NHL. In nested studies using Cox regression models on individual participant data, we found that, after adult leukemia, the multivariate adjusted hazard ratios were 4.9 (95% confidence interval [CI], 2.8-8.5) for thyroid cancer, 1.9 (95% CI, 1.2-3.1) for brain cancer, and 3.3 (95% CI, 2.5-4.4) for NHL. Corresponding hazard ratios after childhood leukemia were 10.4 (95% CI, 0.4-223) for thyroid cancer, 7.2 (95% CI, 2.0-26) for brain cancer, and 6.5 (95% CI, 0.4-110) for NHL. Patients with adult leukemia have excess risk of thyroid cancer, brain cancer, and NHL, similar to patients with childhood leukemia.

AB - Patients with childhood leukemia surviving into adulthood have elevated risk of developing thyroid cancer, brain cancer, and non-Hodgkin lymphoma (NHL); these risks cannot automatically be extrapolated to patients surviving adult leukemia. We tested whether survivors of adult leukemia are at increased risk of developing thyroid cancer, brain cancer, and NHL. We included the entire adult Danish population (14 years of age or older), in a 28-year follow-up period from 1980 through 2007, composed of 6 542 639 persons; during this period, 18 834 developed adult leukemia, 4561 developed thyroid cancer, 13 362 developed brain cancer, and 15 967 developed NHL. In nested studies using Cox regression models on individual participant data, we found that, after adult leukemia, the multivariate adjusted hazard ratios were 4.9 (95% confidence interval [CI], 2.8-8.5) for thyroid cancer, 1.9 (95% CI, 1.2-3.1) for brain cancer, and 3.3 (95% CI, 2.5-4.4) for NHL. Corresponding hazard ratios after childhood leukemia were 10.4 (95% CI, 0.4-223) for thyroid cancer, 7.2 (95% CI, 2.0-26) for brain cancer, and 6.5 (95% CI, 0.4-110) for NHL. Patients with adult leukemia have excess risk of thyroid cancer, brain cancer, and NHL, similar to patients with childhood leukemia.

U2 - http://dx.doi.org/10.1182/blood-2011-02-337170

DO - http://dx.doi.org/10.1182/blood-2011-02-337170

M3 - Journal article

VL - 118

SP - 4062

EP - 4069

JO - Blood

JF - Blood

SN - 0006-4971

IS - 15

ER -

ID: 40144868